Annie Papadaki1,2, M. Jorge Cardoso3, Stephen J. Wastling1,2, Tarek Yousry1,2, Ludvic Zrinzo4, Indran Davagnanam1,2, and John S, Thornton1,2
1Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, University College London Hospital, London, United Kingdom, 2Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, London, United Kingdom, 3Translational Imaging Group, Centre for Medical Image Computing (CMIC), Department of Medical Physics and Bioengineering, University College London, 4Unit of Functional Neurosurgery, Institute of Neurology, University College London
Synopsis
We modified routine clinical head MRI
protocols to be compliant with a new MR conditional product label for deep brain
stimulation (DBS) devices limiting B1+RMS to ≤2.0μT. 12 healthy volunteers were scanned
using the routine and modified protocols. Quantitative signal to noise (SNR)
and contrast to noise ratio (CNR) analysis was performed, as well as blinded rating
of images by a neuroradiologist. Routine and B1+RMS -limited
sequences yielded very similar SNR and grey vs.
white matter CNR values, indicating that the B1+RMS condition had
been achieved with minimum impact on image quality, consistent with the neuroradiologist’s
qualitative assessment.
PURPOSE:
To date patients with deep brain stimulation (DBS) devices
have effectively been denied formal access to MRI due to safety concerns. For
certain devices product label-compliant MRI had been limited to brain imaging only
using a transmit/receive head coil and very low specific absorption rate (SAR<0.1W/Kg).
These restrictions meant that relatively few centres offered MRI to patients
with MR conditional DBS implants, and then with compromised diagnostic quality.
Scanner-reported B1+RMS has been proposed as an alternative metric
to control RF power deposition for specific implants1,2. In 2015
Medtronic introduced significant changes to the MR Conditional labelling for their
DBS systems. In particular, DBS patients with eligible systems can now be scanned anywhere in the body using the
whole body transmit coil up to a B1+RMS limit of 2.0μT in addition
to other restrictions detailed in the product labelling. The purpose of this
study was to establish in healthy volunteers the feasibility of clinical routine
brain MRI protocols compliant with B1+RMS≤2.0μT, taking into account
acquisition time compromises and the resulting image quality.METHODS:
Twelve healthy adult volunteers underwent MRI at 1.5T
(Siemens Avanto) in whole-body transmit mode with the standard 12-channel
receive only head coil. Coronal T2 weighted, coronal FLAIR and axial T1
weighted brain scans were acquired for each subject with both clinical
sequences used routinely in our neuroradiology centre, and locally optimised
sequences where the B1+RMS was limited to 2.0μT, without repositioning between scans.
The SNR, CSF vs. brain CNR, grey vs. white matter CNR, image sharpness and
artefacts were rated by an experienced neuroradiologist who was blinded to the
sequence type. Additionally for each data set quantitative analysis was
performed based on anatomical labelling using a geodesic information flow
approach3: the total white matter and cortical grey matter SNRs and
the total white vs. cortical grey matter CNR were computed, to enable
statistical comparison between the routine and B1+RMS -limited
protocols.RESULTS:
For both T2 and T1-weighted sequences scan time was
increased in the B1+RMS limited versions compared to the original
due to changes in TR, Turbo factor and number of concatenations, whilst for the
FLAIR the B1+RMS reduction was achieved simply by changing the RF pulse
type, thus scan time remained the same (Table 1). There was a 28.7% increase in
total scan time with the modified protocol. For the B1+RMS limited
sequences, head SAR varied between 0.5-1.1 W/kg according to body-weight and
other contributing factors, whilst the B1+RMS as expected was
essentially constant between subjects. All
images were considered to be of a clinically diagnostic standard: the
per-subject inter-scan differences were in general small, for nearly all
assessments in each of the three contrast-weightings, for the majority of
subjects the quality of the B1+RMS limited scans was either
equivalent to, or exceeded, the performance of our routine protocols. For the B1+RMS-limited
T1 weighted scans an increase in artefacts mainly related to motion was
observed presumably due to the increased number of concatenations and
consequently longer scan time, but this also led to reduced slice-slice cross talk compared with the equivalent routine protocol. Quantitative
analysis for the routine and B1+RMS -limited sequences yielded very
similar SNRs and GM/WM CNRs, indicating that the B1+RMS condition
had been achieved with minimum impact on these measures. SNR, CNR and p-values
from paired tests are shown on Table 2.DISCUSSION /CONCLUSION:
B1+RMS limited product-label compliant
versions of routine brain protocols were created by adjusting sequence parameters
while aiming to maintain image quality. Quantitative image analysis and
radiologist image review showed new sequences produce images of similar or marginally
better image quality to the routine protocols currently being used in our
centre. This protocol will allow a growing number of patients with in situ DBS
systems to undergo neurological MRI examinations.Acknowledgements
Medtronic PLC provided research funding; the work was supported by the NIHR
UCLH Biomedical Research Centre.References
1.
EN 60601-2-33:2010 A1:2015 Medical
electrical equipment Part 2-33: Particular requirements for the basic safety
and essential performance of magnetic resonance equipment for medical diagnosis;
2. ISO/TS10974:2012 Assessment of the
safety of magnetic resonance imaging for patients with an active implantable
medical device;
3. M. J. Cardoso, M. Modat, R. Wolz, A. Melbourne, D. Cash, D. Rueckert,
and S. Ourselin, Geodesic Information Flows: Spatially-Variant Graphs and Their
Application to Segmentation and Fusion, 2015 IEEE Transactions on Medical
Imaging, vol. 34, no. 9, pp. 1976-1988